Browse by author
Lookup NU author(s): Professor Mark Cunningham
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The anticonvulsant, valproic acid (VPA), has a very wide spectrum of clinical activity and has conventionally been considered to act by enhancing inhibitory GABAergic activity, either by increasing GABA levels and its subsequent release or by enhancing postsynaptic GABA responses. However, the pharmacology of VPA is complex and other mechanisms may well contribute. In the present study, we examined the effect of the drug on the release of GABA and glutamate at synapses in the rat entorhinal cortex, using the whole-cell patch clamp technique to record spontaneous excitatory (sEPSCs) and inhibitory postsynaptic currents (sIPSCs). VPA reduced the frequency but not the amplitude of both spontaneous sEPSCs and sIPSCs, with a more pronounced effect on the former. However, VPA had no effect on miniature, monoquantal events recorded in the presence of TTX, suggesting that the reduction in release occurred via blockade of Na+-channels in the presynaptic neurones. In addition, VPA also prolonged the decay time of sIPSCs, and this effect was occluded by a benzodiazepine agonist, zolpidem. These data suggest that in addition to presynaptic effects on release, VPA can potentiate postsynaptic responses, possibly by interaction with the benzodiazepine regulatory site of the GABAA receptor.
Author(s): Cunningham MO; Woodhall GL; Jones RS
Publication type: Article
Publication status: Published
Journal: Neuropharmacology
Year: 2003
Volume: 45
Issue: 7
Pages: 907-917
ISSN (print): 0028-3908
ISSN (electronic): 1873-7064
Publisher: Pergamon
URL: http://dx.doi.org/10.1016/S0028-3908(03)00270-3
DOI: 10.1016/S0028-3908(03)00270-3
PubMed id: 14573383
Altmetrics provided by Altmetric
